HCA Healthcare

Stock

Ticker: HCA

HCA

Price

Discussion about HCA

Posts

Homer

@Simpson

2Mon·

HCA Healthcare Second-Quarter 2026 Results

$HCA (+0.13%)

Source

https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Reports-Second-Quarter-2026-Results/default.aspx

Homer

@Simpson

4Mon·

Ultimate Homer Hardcore Holding Results May 2026

There was no sign of a sell in May and May delivered a stable return 💪😁 Allianz also paid the highest dividend of the year 🤑

As far as new investments are concerned, there was a little "fine tuning" in the portfolio, $BMI (+1.05%) and $SNPS (+0.19%)

were liquidated, which together accounted for around 1% of the portfolio.

I used the money to invest in $MUV2 (-0.35%) and $HCA (+0.13%) to lay the foundation.

11 Comments

AI sagt@GoDividend

4Mon

So approx. 4% price gains in May? Could be right?

•

View all 7 further answers

Homer

@Simpson

5Mon·

New position in the Ultimate Homer Hardcore Holding

What kind of shit is it that the texts are deleted when posting from time to time? The problem has been going on for weeks and no solution in sight?😅

The position is not entirely new, I already had it in the Ultimate Homer savings plan portfolio.

A hospital operator from the USA, business is going well so far, stable share buyback program, should bring long-term returns.

Last earnings April 2026

Source

https://s23.q4cdn.com/949900249/files/doc_financials/2026/q1/FINAL-PR_HCA-Reports-1Q-2026-Results.pdf

20.05

HCA Healthcare

Bought x1 at €342.15

€342.15

Josh

@Josh_44

1Yr·

Purchases for next week:

1 Meta Platforms (A)

Meta is investing heavily in AI and the metaverse - an exciting tech giant with solid cash flow after the correction.

2. paypal

Fintech giant with a strong market position in digital payments - currently valued more favorably due to the correction.

3. realty income

Stable dividend payer ("Monthly Dividend Company") from the real estate sector - down due to interest rate concerns, now an attractive entry point.

4. salesforce

Market leader in CRM software with good growth prospects - the correction is pushing the price down to a more interesting level.

5 Shopify (A)

E-commerce enabler with potential to profit from global online trade - more attractive again after setbacks.

6. target

Solid retail company with stable sales - fallen due to economic uncertainties and now valued more excitingly.

7 The Trade Desk (A)

Profiteer of growing digital advertising - currently cheaper due to tech sector correction.

8 Zeta Global Holdings

Growing in data-driven marketing - still a small cap with opportunities due to current valuation weakness.

9 Alphabet (A)

Google parent with strong AI and cloud position - correction offers long-term investors favorable entry opportunities.

10. amazon.com

Market leader in e-commerce and strong in the cloud sector (AWS) - currently more exciting again after declines.

11. ASML

Monopolist in EUV lithography machines for the chip industry - cheaper due to market downturn, but essential in the long term.

12. diageo

Strong consumer goods stock (e.g. spirits) - currently under pressure due to economic concerns, which creates good opportunities for additional buying.

13. HCA Healthcare

Largest private hospital operator in the USA - defensive business model, more interesting valuation after the correction.

14. Lam Research

Important supplier for the semiconductor industry - currently affected by the weak semiconductor market, but enormously important in the long term.

With these words, I wish you a pleasant Sunday evening and a successful week! $META (+0.76%)
$LRCX (+1.53%)
$HCA (+0.13%)
$DGE (-0.81%)
$ASML (+1.38%)
$AMZN (+0.01%)
$GOOGL (+0.23%)
$ZETA (+0.75%)
$TTD (+0.18%)
$TGT (-0.36%)
$SHOP (+0.07%)
$CRM (-0.36%)
$O (+0.1%)
$PYPL (-0.65%)

#etfs
#dividends
#stockanalysis
#aktien
#tech

9 Comments

Paul@paul_finesse_

1Yr

I would still keep an eye on PayPal at the moment. They are currently at absolute support, which must hold. If they now break below usd 66 on a sustained basis, the share will again have good downside potential. I would therefore wait and see whether we hold the support.

•

Aktien Stammtisch

@Aktien_Stammtisch

1Yr·

HCAHealthcare Q4 FY2024 EarningsReport Summary

$HCA (+0.13%)

In Q4 2024, HCA Healthcare demonstrated growth in revenue and operating metrics but faced profitability challenges due to hurricane-related disruptions. Strategic initiatives supported admissions growth, though outpatient procedures declined.

📊 Income Statement Highlights (vs Q4 2023):

▫️Net Income: $1.44B vs $1.61B (-10.51%)

▫️Total Revenue: $18.29B vs $17.30B (+5.68%)

▫️Adjusted EPS: $6.22 vs $5.90 (+5.42%)

▫️Gross Margin: 11.67% vs 12.33%

▫️Operating Income: $2.13B vs $2.18B (-2.29%)

▫️Adjusted EBITDA: $3.71B vs $3.62B (+2.55%)

▫️Same Facility Revenue/Equivalent Admission: $18,185 (+2.9%)

Other Metrics:

▫️Same Facility Admissions: +3.0%

▫️Emergency Room Visits: +2.4%

▫️Inpatient Surgeries: +2.8%; Outpatient Surgeries: -1.3%

💼 Balance Sheet Highlights (vs Dec 31, 2023):

▫️Total Assets: $59.51B (+0.94%)

▫️Cash and Cash Equivalents: $1.93B (+106.68%)

▫️Total Liabilities: $43.03B (+0.23%)

▫️Equity: $0.56B

Other Key Figures:

▫️Debt: $43.03B

▫️Share Repurchases: $1.70B in Q4; $764M remains under authorization.

▫️Capital Expenditures (excluding acquisitions): $1.29B

🔮 Future Outlook:

▫️2025 Revenue Guidance: $72.80B to $75.80B

▫️Net Income: $5.85B to $6.29B

▫️Adjusted EBITDA: $14.30B to $15.10B

▫️EPS: $24.05 to $25.85

▫️Capital Expenditures: $5.0B to $5.2B

🌟 Special Considerations:

▫️Hurricanes Helene and Milton impacted operations, contributing to a $200M revenue loss. All facilities have resumed normal operations.

▫️HCA’s board authorized an additional $10B share repurchase program.

▫️Q4 2024 dividends declared: $0.72/share.

David

@daviddg

2Yr·

Just wanted to share a little test I'm using as benchmark:

I selected by screener the biggest 10 companies by Market Cap with these parameters:

ROIC > 15%
Net debt / EBITDA LTM <3x
Total return 5Y >100% (20% CAGR)
PE NTM <40x
Analysts Estimated EPS Forwards 5Y CAGR >12%

Equal weighted buying in January 2nd 2024

Results:

$UNH (-0.19%) (I removed this because the PE LTM was too close to 40)

$NFLX (+0.23%)

$QCOM (+0.62%)

$PGR (-0.01%)

$BKNG (-0.6%) (I removed this one total return 5Y was too close to 100%)

$LRCX

$KLAC (+0.46%) (added the next one to replace the removed one)

$HCA (+0.13%) (same)

I know that in January the screener results maybe wouldn't be these, and that most companies are the easy ones, but... 30% returns YTD, without using the 10 best performance of the SP500 YTD ($NVDA (-0.02%) , $VST (+0.9%) , $SMCI , $HWM (+0%) , $CEG , $TRGP (-0.31%) , $LLY (-0.93%) , $IRM (+0.25%) , $NRG (+0.3%) , $GDDY (-0.01%) and no crypto,)